Scholarlink

Background <p>Based on the pathological characteristics of lung adenocarcinoma in situ (AIS), conventional histopathological understanding suggests that non-small cell lung cancer (NSCLC) cells should not penetrate the basement membrane to enter systemic circulation. When cancer cells enter the blood circulation and form circulating tumor cells (CTCs) or even circulating tumor microemboli (CTM), they may trigger cancer metastasis. CASE PRESENTATION: In three AIS patients, we detected heterogeneous populations of CTCs and CTM in peripheral blood using the CTCBIOPSY<sup>®</sup> system-a finding that possibly contradicts established AIS pathomorphological criteria.</p> Conclusion <p>Our findings suggest that CTCs/CTM may possess occult metastatic potential, indicating a dormant risk of micrometastasis even in AIS. Therefore, we believe that CTCs/CTM can serve as essential preoperative examination indicators for evaluating the prognosis of lung cancer patients and determining their treatment plans.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Detection of circulating tumor cells and microemboli in the blood of lung adenocarcinoma in situ patients case reports

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月22日

查看全文
  • Yubin Huang,
  • Houlu Zhang,
  • Daming Fan,
  • Zerui Wang,
  • Xuanzhe Qin,
  • Xiaoming Sun,
  • Liangming Zhu

摘要

Background

Based on the pathological characteristics of lung adenocarcinoma in situ (AIS), conventional histopathological understanding suggests that non-small cell lung cancer (NSCLC) cells should not penetrate the basement membrane to enter systemic circulation. When cancer cells enter the blood circulation and form circulating tumor cells (CTCs) or even circulating tumor microemboli (CTM), they may trigger cancer metastasis. CASE PRESENTATION: In three AIS patients, we detected heterogeneous populations of CTCs and CTM in peripheral blood using the CTCBIOPSY® system-a finding that possibly contradicts established AIS pathomorphological criteria.

Conclusion

Our findings suggest that CTCs/CTM may possess occult metastatic potential, indicating a dormant risk of micrometastasis even in AIS. Therefore, we believe that CTCs/CTM can serve as essential preoperative examination indicators for evaluating the prognosis of lung cancer patients and determining their treatment plans.